The
White House announced more
than $8 billion in commitments to the "food is medicine" movement
linking nutrition and chronic illness, including $2.5 billion for investments
in startups addressing food insecurity.
Gilead
Sciences keeps cracking down on fake HIV drugs. In a new lawsuit, the
company detailed how two "kingpins" led a "large-scale, sophisticated
counterfeiting conspiracy," and how it made every effort to expose the
alleged criminals.
When Biohaven sold its migraine franchise to Pfizer for more than $11 billion this year, there was hope another gem was somewhere in its pipeline. But the company has since gone 0 for 2 in trial readouts, now with verdiperstat failing in patients with ALS compared to placebo. - Conor Hale
No comments:
Post a Comment